US Patent No. 9,164,098

Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample
Oct 23, 2015

Bruker Daltonik has been awarded US Patent No. 9,164,098, "Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample."

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.